Kiniksa Pharmaceuticals Ltd. announces that Phase II clinical trial data for its investigational drug KPL-387 is expected to be released in the second half of 2026.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
In addition, the company plans to initiate Phase III clinical trials of the drug by the end of this year.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Google rises over 3%
格隆汇•2026/05/13 16:32
German bond yields opened lower but moved higher.
华尔街见闻•2026/05/13 16:31
error
BlockBeats•2026/05/13 16:15
IMF President: If oil prices remain high in 2027, there is a risk of economic recession
华尔街见闻•2026/05/13 16:13
Crypto prices
More
Bitcoin
BTC
$79,094.67
-1.23%
Ethereum
ETH
$2,250.28
-0.33%
Tether USDt
USDT
$0.9995
-0.01%
BNB
BNB
$668.91
+2.46%
XRP
XRP
$1.42
-0.32%
USDC
USDC
$0.9998
-0.00%
Solana
SOL
$90.96
-3.20%
TRON
TRX
$0.3501
+0.64%
Dogecoin
DOGE
$0.1117
+3.20%
Hyperliquid
HYPE
$39.13
-2.87%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now